Investors’ data
Latest news
- December 10, 2008
Thallion Announces a Review of Strategic Alternatives
- November 18, 2008
Thallion Initiates Enrollment in Phase II Metastatic Melanoma Trial
- October 24, 2008
Thallion's TLN-4601 Inhibits Mutated K-RAS Signaling in Cancer Cells
Documentation
Financial Reports
A complete list of all filings can be found on www.sedar.com
All documents are in PDF format